Noscendo raises €2.0M Seed round
25 October 2018· Duisburg, Germany· health, diagnostics, ai, biotech, b2b, pure_software
The capital will be used for the technical development and commercialization of the company's NGS-based diagnostic platform for identifying pathogens in patients with bloodstream infections.
Investors
LeadWieland Capital
Also participating
High-Tech Gründerfonds
About Noscendo
Stage
Growth
Headquarters
Duisburg, Germany
Founded
2017
Team Size
21–50
Sectors
healthdiagnosticsaibiotechb2bpure_software